Amedisys, Inc. (NASDAQ:AMED) Holdings Lifted by Alpine Associates Management Inc.

Key Points

• Alpine Associates Management Inc. increased its stake in Amedisys, Inc. by 11.7% during the first quarter, purchasing an additional 104,000 shares to reach a total of 992,120 shares.
• Amedisys reported a quarterly EPS of $1.54, surpassing analyst estimates by $0.15, and saw a 5.2% increase in revenue compared to the previous year.
• Analysts have mixed ratings for Amedisys, with Wall Street Zen lowering its rating from "strong-buy" to "buy," while Royal Bank of Canada maintained an "outperform" rating with a $100.00 price target.

Alpine Associates Management Inc. grew its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 11.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 992,120 shares of the health services provider's stock after purchasing an additional 104,000 shares during the quarter. Amedisys makes up 4.8% of Alpine Associates Management Inc.'s portfolio, making the stock its 7th biggest position. Alpine Associates Management Inc. owned 3.02% of Amedisys worth $91,900,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the stock. Norges Bank purchased a new stake in Amedisys during the fourth quarter worth $83,061,000. Pentwater Capital Management LP boosted its holdings in Amedisys by 178.3% during the fourth quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock worth $107,132,000 after buying an additional 756,000 shares in the last quarter. AQR Arbitrage LLC boosted its holdings in Amedisys by 59.1% during the fourth quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock worth $42,812,000 after buying an additional 175,311 shares in the last quarter. Toronto Dominion Bank acquired a new position in Amedisys during the fourth quarter worth $15,801,000. Finally, CIBRA Capital Ltd raised its position in Amedisys by 359.7% during the first quarter. CIBRA Capital Ltd now owns 216,775 shares of the health services provider's stock worth $20,080,000 after acquiring an additional 169,616 shares during the period. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Stock Performance

AMED traded down $0.03 on Monday, hitting $98.48. 245,250 shares of the company traded hands, compared to its average volume of 366,223. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $3.24 billion, a PE ratio of 38.34, a PEG ratio of 1.33 and a beta of 0.89. The company has a 50 day moving average of $96.75 and a 200-day moving average of $94.20. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $99.00.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.15. The company had revenue of $621.86 million for the quarter, compared to analysts' expectations of $614.61 million. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. Amedisys's revenue was up 5.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.98 EPS. Sell-side analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AMED has been the subject of a number of research analyst reports. Royal Bank Of Canada restated an "outperform" rating and set a $100.00 price objective on shares of Amedisys in a research report on Wednesday, April 16th. Wall Street Zen cut shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.